IXC has not had a decent bounce at all as yet, maybe still some sellers lurking. Latest Posts. Created with Sketch. Charts. . . Created with Sketch. Created with Sketch. Initial FDA and EMA Advice on Presendin Development, page-3. ASX - By Stock. 59). Forums. 3. See page-34. 0¢ Sentiment: Buy Disclosure: Held. Charts. 2 Upvote. . pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. Folks say we are pioneers of craft ice cream in Victoria. . Created with Sketch. Charts. Theres alot of breakdowns above that are yet to be backtested. , page-188. Anyone buying now can carry to $5 and then sell a few prior to readout as insurance against losing everything in the coin flip. The Calmer Co (ASX:CCO) breaks new ground in Australian Retail with Kava shots to launch in Coles from January 2024Hi guys, after discussion with Tom I have kind of mapped out the timeline to what is to be achieved. Join the HotCopper ASX share market forum today for free. 147,415. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. , page-5. Created with Sketch. Update - Notification regarding unquoted securities - IXC. ASX - Day TradingCreated with Sketch. Market Cap $16. . , page-5. Cannot wait. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-3. Orphan drug status. 5¢ Sentiment: Buy Disclosure: Held. . IXC Price at posting: 44. But the market volume was very low, which points to a lack of interest, the long horizons of biotech, lack of publicising or Notification of cessation of securities - IXC. Created with Sketch. ASX - By Stock. View daily, weekly or monthly formats back to when Invex Therapeutics Ltd stock was issued. There can't be many left who have a positive association with this stock (apart from seed investors), so I don't think token $10-20k director purchases will change anything. , page-4. Latest Posts. Australia's largest stock trading and investment forum Australia's #1 stock forumInvestor PresentationMRDMount Ridley Mines REE Project: Drilling confirms continuous high-grade mineralisation. ASX - By Stock. ASX - Day TradingInvex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. 30 order I had out there for 2-3 weeks. Target our investor community with our suite of Hotcopper Advertising opportunities. Results are our big catalyst Other catalysts include: - new indication - directors buying - half way through trial (120 patients recruited)At the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. com. DJPIN. Lots of possible reasons for this - but regardless, it points to Tom knowing that there is upside to this current SP. , page-3. . Join the HotCopper ASX share market forum today for free. . Good fundamental research starting points for IXC:Summary: IXC FactsheetMST Analyst Equity Research ReportFiftyOne Capital ReportPresentation - Tom Duthy. Market . IXC below Example of that is NEU Investor Presentation, page-3. . 9 more clinical sites to be rapidly activated in a country with a growing incidence of IIH cases. Forums. ASX - By Stock. Only took that large seller to sell, now liquidity has dried up and. , page-4. wonder if the GLP-1 agonist referred to in this media release. 1950. A new thread to put trading comments / reasoning / opinions in. Created with Sketch. Share “Exercise Price Subject to paragraph (j), the amount payable upon exercise of each Option will be the 50% premium to the 30 day VWAP immediately prior to the Meeting (Exercise Price). Given that IXC's Chief Scientific Officer, Alex Sinclair, is the author of IIH treatment guidelines, the introduction of an effective medication to the market would likely lead to a rapid integration of Presendin into treatment protocols. Market . Forums. ASX - Day Trading It is certainly an interesting case study regarding management strategy; that noted strategy would work during fair or bullish markets as participants are acting rationally (and by sticking to their knitting during Covid Crash the IXC share price bounced back heavily with Phase II results - so perhaps thats what they were thinking would happen. . ASX - Day Trading. Mernova, a subsidiary of Melodiol Global Health (ASX:ME1), is on track to achieve its highest ever monthly sales, with revenues expected to reach A$891,944 in October 2023. . Created with Sketch. Advertise on HotCopper. you post every single trade that is a sell onto Hotcopper. Advertise on HotCopper. Notice of Annual General Meeting/Proxy FormInvex Receives Written Response from FDA on Type C MeetingNotification of cessation of securities - IXC. I'm topping up. IXC is at base, so it’s just a matter of when it’ll leave base and start turning to the upside. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. . , page-3. About 90 percent of the U. Created with Sketch. Hopefully they hit the miracle, at least I get something back from this if it goes balls up which in the bio world at the moment is highly likely. Created with Sketch. Forums. 54am 24/11/2023 ? HotCopper has news, discussion, prices and market data on INCA MINERALS LIMITED. . It's essentially a cashed up shell company right now it. , page-6. . Created with Sketch. ASX - By Stock. Created with Sketch. . ASX - General. ASX - By Stock. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. All the latest Invex Therapeutics Ltd (ASX:IXC) share price movements, news, expert commentary and investing advice from The Motley Fool Australia. Appendix 4C - quarterly* or having a go at doing so, page-30. 0¢ Sentiment: Buy Disclosure: Held Created with Sketch. Created with Sketch. IXC Price at posting: 37. Created with Sketch. Market . Investor PresentationI would be worried about holding IXC if they had no more cash. Been. ASX - Short Term Trading. Forums. 50%. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. But there are two key factors that make me hope that the BoD pursues the Phase 2, but I worry that JP and co will push for the. Results of MeetingInvex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. Join the HotCopper ASX share market forum today for free. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. IXC needs to be proactive and release a statement. Click for more information. Get the edge as an investor: Subscribe to our daily newsletter for EXCLUSIVE insights into HotCopper!. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. ASX - General. Invex to Present at Virtual ASX Small and Mid-Cap ConferenceHealth & BiotechMay 24, 2020|Tim BorehamSHAREFrom the bulging file of Nasty Obscure Diseases we present idiopathic intracranial hypertension (IIH), a. ASX - Day TradingIf IXC is positioning itself as a takeover target and the trial endpoints allow for it, it would make sense to provide early readouts. boolish Jellyroll hey. Advertise on HotCopper. Market . ASX - Day Trading. 30 Haven’t supported share price since then on market . Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. 50%. ASX - By Stock. IXC Valuation Report MST. Consequently, this would result in faster market penetration and an accelerated timeline to peak sales. Created with Sketch. ASX - Day TradingNotice of Webinar & Investor PresentationCreated with Sketch. Postcard to ShareholdersIXC (ASX) Ann: Trading Halt - HotCopper. More. Global Phase 3 Trial of Presendin to Launch in Q4 2021, page-2. 0 Million. Read in the announcement, has changed name and he has bought more ixc, page-2. ASX - By Stock. Created with Sketch. 0% $ODM 35. Advertise on HotCopper. I think having this out we can discuss on the way. I don't mind a capital return but you have to think that a reverse take over of some sort can happen here and that IXC would have lots of choices. ASX - By Stock. 8 Upvote Created with Sketch. In 2005, IIH cost the American health care. Bumping up this thread as $3. . ASX - Day TradingQuarterly Activities/Appendix 4C Cash Flow ReportMarch 20 (Reuters) - Invex Therapeutics Ltd (IXC) : APPROVAL TO COMMENCE IIH EVOLVE PHASE III CLINICAL TRIAL RECEIVED FROM BUNDESINSTITUT FÜR. 0% $ODM 35. Results of MeetingFor those curious about the T20 moves over the last 2 months of available data;Underlined = UnchangedGreen = Positive ChangeRed = Negative ChangeDYOR, not. ASX - Day TradingAlthough with IXC fully cashed up it makes this fall irrational and the odd one out of alot of these small cap speccies that are death spiralling - aka, opportunity . Forums. Lucky for you all IXC still sits at only 60 cents. 54pm 22/11/2023 ? HotCopper has news, discussion, prices and market data on INVEX THERAPEUTICS LTD. Just a matter of time really. Created with Sketch. Invex Therapeutics' Chief Scientific Officer, Professor Alexandra Sinclair, met with NASA's medical team. ASX - Day TradingHere's a very good opportunity for people in Sydney. ASX - Day TradingCreated with Sketch. , page-5. Discover historical prices for IXC. 31% more bullish than other Healthcare sector stocks. Ceasing to be a substantial holderAustralian finance news, stock quotes, currency information and blogsQuarterly Activities/Appendix 4C Cash Flow ReportInvex Granted European Patent for Exenatide in Hydrocephalus. 0¢ Sentiment: Buy Disclosure: Held. Forums. ASX - By Stock. ASX - General. Market Wrap - Top 3 Gainers #ASXGainers: $IXC 54. What would you like to pay the world leader in IIH science as CSO, and how much of that salary you would expect to be spent on market to buy shares? Hi All, Having scrolled through the IXC forum for 18-24 months now, I have seen quite literally 200+ posts of charts discussing the stock price, and only a handful of posts discussing the fundamental analysis of the business itself, Publication of Invex IIH Phase II Pressure Trial Results. Exciting times now that IXC is finally on the map!!! FYI considering charting is subjective that 1. 1950. . When can we expect some update or. . Latest Posts. Can't see how this doesn't push up soon, page-508. 9MB OEC: 22/11/2023 1:05 PM : Cleansing Notice 2 pages 172. . ASX - Short Term Trading. Target our investor community with our suite of Hotcopper Advertising. ASX - Day Trading. ASX - By Stock. . As thread states post your questions here and let’s start compiling a list. It was well aware of the claims made, released such information in the prospectus (and still had a hugely successful IPO), and would have done their due diligence before entering into any agreements with the University. 7KB AVG: 22/11/2023 1:08 PM : 2023 AVG AGM Addresses and Presentation 35 pages 3. 0. ASX - By Stock. Jellyroll, arkangel, CD, balkanbroker to name a few have laid out some pretty compelling thesis' on where IXC will be heading. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. ASX - By Stock. 1. Charts. Investor PresentationInvex Successfully Concludes Protocol Assistance with EMACreated with Sketch. 1950. ASX - By Stock. Yet since market announcement of Phase 2 completion, this. ASX - By Stock. IXC on the other hand with nearer catalysts has already done its basing cycle Of course different stock different TAMS etc etc, probably why IMU is worth 640 mill MC and IXC 28 mill MC But again its why IXC is offering so much more in terms of value atm plus risk v reward All IMO of course, but yeh maybe some IMU investors pop across. ASX - Day Trading. Market . Notification of cessation of securities - IXC. ASX - By Stock. ASX - General. Australia's largest stock trading and investment forum Australia's #1 stock forum Australia's #1 stock forumUK R&D Tax Rebate. 0¢ Sentiment: Buy Disclosure: HeldHotCopper has news, discussion, prices and market data on GENESIS MINERALS LIMITED. EGREcoGraf partners with VinES Energy for pioneering Battery Anode Material Facility in Vietnam. Created with Sketch. We are supported by a Board of Advice which is made up of the premier leaders in the various fields in which we, Private Capital Advisers, specialise. Consequently, this would result in faster market penetration and an accelerated timeline to peak sales. ASX - Day TradingTo name a few other biotechs that have gotten belted by the market of the last few months that have had decent bounces such as NOX, NYR and PEB. Release Date: 20/03/23 08:11; Summary: German Approval for IIH EVOLVE Phase 3 Clinical Trial; Price Sensitive: Yes; Download Document 195. . 38 Biotechnology stocks are valued based on a risk. Access the latest research articles and market investment insight for INVEX THERAPEUTICS LTD seamlessly. ASX - By Stock. ASX - Day Trading. 1956773. Management have earmarked this a significant milestone - given they previously tied it to performance. All IMO IXC Price at posting: 37. Forums. IXC Price at posting: 23. IXC Price at posting:. Liked by Jackie Cox-Ziegler, CPHR. 0. . Share I've got no issues with it. ASX - Day TradingAs thread states post your questions here and let’s start compiling a list. Forums. Hi All, Having scrolled through the IXC forum for 18-24 months now, I have seen quite literally 200+ posts of charts discussing the stock price, and only. , page-75. So your thesis is right on a long time time frame. Charts. ASX - Day Trading. ASX - Day TradingInvex Files Pre-IND/Type B Meeting Request with US FDA, page-2. ASX - Day Trading. ASX - Day TradingCreated with Sketch. Created with Sketch. Sentiment for Invex Therapeutics Ltd. ASX - Day Trading. Friday we moved 55% off 690k volume. Created with Sketch. Created with Sketch. ASX - By Stock. ASX - By Stock. You are the controller for IXC, you call the shots to make the company as best as possible for shareholders - this means retaining talent and forwarding the company to Phase III success and beyond. June 15 (Reuters) - Invex Therapeutics Ltd (IXC) : INVEX RECEIVES WRITTEN RESPONSE FROM FDA ON TYPE C MEETING ON PHASE III CLINICAL TRIAL DESIGN FOR. Target our investor community with our suite of Hotcopper Advertising opportunities. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-4. Created with Sketch. ASX - General. Charts. Created with Sketch. More progress made towards the start of Phase III, we have now made it on to the clinicltrials. Created with Sketch. Notice of Quarterly Investor Call. Just unfortunate to hit the black swan so badly here, both the. All IMO IXC Price at posting: 37. 0. Of course IXC isnt the stock market but its coincidental that selling has stopped around this 17 cents mark which aligns with the old trend line from back in the days. Quarterly Activities/Appendix 4C Cash Flow Report. 31% more bullish than other Healthcare sector stocks. At the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. A promising development for IXC, a company with a current Phase III trial that is expected to finish dosing in 12 months time, We hear from a patient from the Phase II trial completed 2 years ago, with our current Phase III trial ongoing as we speak:Simon Joyner - 14th largest holder in IXC Just a background of this board of advice. Invex to Present at Upcoming Tech Biotech Broker BriefingCreated with Sketch. Latest Posts. . . Latest Posts ForumsiShares Global Energy ETF (IXC) Add to watchlist NYSEArca - Nasdaq Real Time Price. here (arrow) per the NEU chart Close now to breaking trend and establishing a more upper trend into results IMO IXC Price at posting: 40. Probably been disappointed like all of usCreated with Sketch. Both approaches can work, but it is not wise to confuse the two. A handy 10 bags from here with seemingly little risk. Invex Granted Key European Patent for Exenatide, page-2. IXC. ASX - Short Term Trading. Created with Sketch. 147,415. Just another way to saying that we've got Patient 1 out of 240. 6B TAM that is unencumbered and a 55% peer average neurology success rate from Phase 3!IXC although only the 1 indication has already raised the sufficient cash to go all the way, they are in phase 3 trials, they have a time line and are full steam ahead. **Close price adjusted for splits and dividend and/or capital gain distributions. I think having this out we can discuss on the way. 20. Exciting times now that IXC is finally on the map!!! FYI considering charting is subjective that 1. Created with Sketch. Discover historical prices for IXC. Market . Also took placement stock @$1. 06KBNotification of cessation of securities - IXC. ASX - Day Trading. Share IXC needs to be proactive and release a statement. . 147,415. Share Well this is unexpected, for the first time ever for Invex, a director has purchased shares on-market. Market . Last updated 10. About 90 percent of the U. Created with Sketch. So it seems that as of 18 July the trials are still recruiting! An update was submitted to this site 3 days. Latest Posts. , page-2. Very impressive. Maybe more common that what people think, imagine once GPs start diagnosing it even better if a treatment is developed, Prevalence could increase 2 or times which ultimately increases. RAC went from 30 cents to $4 in the space of 5 months PAR went from 30 cents to $4 in the space of 1 and half years NEU went from $1. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical developmentNotice of Annual General Meeting/Proxy Form. 05. Invex issued US patent for Traumatic Brain Injury. Created with Sketch. You are still able to buy a potential multi BILLION dollar company in the 50 mill MC range. . Invex Receives Approval for Paediatric Plan from the EMA, page-3. ASX - Short Term Trading. 38 was the valuation MST gave IXC 9 months ago Considering we are now even further de-risked, getting to the end result, wonder what MST valuation would be now. . 54am 24/11/2023 ? HotCopper has news, discussion, prices and market data on INCA MINERALS LIMITED. Anyone had a look at this or put an application in for some stock in the IPO?Created with Sketch. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-2. Invex Therapeutics Ltd. ASX - By Stock. View listing photos, review sales history, and use our detailed real estate filters to find the perfect place. Information. Share 14 mill MC 22 mill cash Like I said they might have gotten rid of Jason and Alex to streamline costs, smartest thing to do is JV with some large pharma let them run trials we get 40% royalty and they get 60% of drug (sell it to them). 79 -0. , page-3. . I see it at perhaps $5 prior to readout. It was well aware of the claims made, released such information in the prospectus (and still had a hugely successful IPO), and would have done their due diligence before entering into any agreements with the University. 7% #asx #ausbiz 23 Jun 2023 06:06:11Not been following IXC but it seems that this Orphan Drug Designation for TBI now have $0 value due to the other Phase III trial update and the company is. 6% $DLM 50. Charts. Update - Notification regarding unquoted securities - IXC. ASX - By Stock. AX stock on Yahoo Finance. 1. 64440. ASX - By Stock. RDN Raiden Resources secures complete control of lithium at Arrow Project, buys out Arrow Minerals Ltd. . . ASX - Short Term Trading. Report to HotCopper and itll be the end of it, cheers. . Sentiment for Invex Therapeutics Ltd. ASX - Day TradingApril 20 (Reuters) - Invex Therapeutics Ltd (IXC) : MINISTRY OF HEALTH APPROVAL FOR IIH EVOLVE CLINICAL TRIAL IN ISRAELInvestor Presentation, page-2. HotCopper has news, discussion, prices and market data on IONIC RARE EARTHS LIMITED. ASX - General. I think IXC has the potential to do better. A promising development for IXC, a company with a current Phase III trial that is expected to finish dosing in 12 months time, We hear from a patient from the Phase II trial completed 2 years ago, with our current Phase III trial ongoing as we speak: Tony Grist - 5th largest holder in IXC Tom Henderson - 2nd largest holder in IXC Kim Hogan - 6th largest holder in IXC and now Simon Joyner - 14th largest holder in IXC Just a background of this board of advice. Slow and steady with IXC. A rolling snowball gathers snow as it falls down the hill . 0. ASX - Day TradingSomeone bought $500 stock today at 44 cents. . Hi All, Having scrolled through the IXC forum for 18-24 months now, I have seen quite literally 200+ posts of charts discussing the stock price, and only. With a team of 68. Transparency is our policy. ASX - General. Below is the broker data for IXC November to. TRP also trades sub cash -5m i believe, haven't checked in a while. ASX - By Stock. . ASX - Day TradingHi all, I would like to preface the below summary written prior to the research links as being a heavily simplified summary of the company and the. Trading HaltCreated with Sketch. Fully funded. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical developmentHREC and TGA Approval to Commence Phase 3 in AustraliaHi guys, after discussion with Tom I have kind of mapped out the timeline to what is to be achieved. 0. is there any news release, or SP increasing due to only the market showing interestInvex Receives UK Approval to Commence Phase III TrialInvex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. Join the HotCopper ASX share market forum today for free. Latest Posts. . IXC Price at posting: $1. Im not expecting anything out of the ordinary apart from the fact thats its overdone and too undervalued at the stage its at. 00 over the course of 2 years, and then doubled to $14 overnight on FDA approval. ASX - By Stock. My understanding is that NEU went from around $1. 3¢. .